Refreshing results…
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Download from www.nature.comAG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Download from aacrjournals.orgIsocitrate dehydrogenase (IDH)2 R140Q mutation induces myeloid and lymphoid neoplasms in mice
Download from www.nature.comTargeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
UploadMissing publications? Search for publications with a matching author name.